Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.

Mizuno Y; Yanagisawa N; Kuno S; Yamamoto M; Hasegawa K; Origasa H; Kowa H

首页> 外文期刊>Movement disorders >Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.

【24h】

Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.

机译：普拉克索与安慰剂和溴隐亭治疗晚期帕金森氏病的随机，双盲研究。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

We compared the efficacy and safety of pramipexole (PPX) with placebo in the treatment of advanced Parkinson's disease (PD) as an adjunct to levodopa. A bromocriptine (BR) group was included to enable determination of the noninferiority of PPX relative to BR as the standard treatment.

机译：我们比较了普拉克索（PPX）和安慰剂作为左旋多巴的辅助治疗晚期帕金森病（PD）的疗效和安全性。包括溴隐亭（BR）组，以能够确定PPX相对于BR作为标准治疗的非劣效性。

著录项

来源
《Movement disorders》 |2003年第10期|共8页
作者
Mizuno Y; Yanagisawa N; Kuno S; Yamamoto M; Hasegawa K; Origasa H; Kowa H;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词
pramipexol; Placebos; Parkinson Disease; Bromocriptine; therapeutic aspects; 安慰剂; 帕金森病; 溴隐亭;

机译：pramipexol;Placebos;Parkinson Disease;Bromocriptine;therapeutic aspects;安慰剂;帕金森病;溴隐亭;

相似文献

外文文献
中文文献
专利

1. Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease. [J] . Mizuno Y, Yanagisawa N, Kuno S, Movement disorders . 2003,第10期

机译：普拉克索与安慰剂和溴隐亭治疗晚期帕金森氏病的随机，双盲研究。
2. Efficacy of pramipexole in the treatment of Parkinson’s disease:a multi-center,randomized,double-blind,bromocriptine-control trial [J] . 温洪波中国医学文摘：内科学分册（英文版） . 2006,第004期

机译：普拉克索对帕金森氏病的疗效：一项多中心，随机，双盲，溴隐亭对照试验
3. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease. [J] . Navan P, Findley LJ, Jeffs JA, Movement disorders . 2003,第2期

机译：双盲，单剂量，交叉研究普拉克索，培高利特和安慰剂对帕金森病患者静息震颤和UPDRS第III部分的影响。
4. The effect of tDCS on ERD potentials: A randomized, double-blind placebo controlled study [C] . Izzidien A., Ramaraju S., Roula M.A., IEEE Symposium on Computational Intelligence, Cognitive Algorithms, Mind, and Brain . 2014

机译：tDCS对ERD电位的影响：一项随机，双盲安慰剂对照研究
5. A double-blind, placebo-control, randomized study investigating the neuropsychological effects of Zyprexa in patients who stutter. [D] . Franklin, David Lawrence. 2003

机译：一项双盲，安慰剂对照的随机研究，研究了Zyprexa对口吃患者的神经心理影响。
6. Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa bromocriptine and pramipexole in healthy subjects [O] . Joëlle Micallef, Marc Rey, Alexandre Eusebio, 2009

机译：抗帕金森病药物引起的嗜睡：健康受试者中左旋多巴溴隐亭和普拉克索的双盲安慰剂对照研究
7. PN4: QUALITY OF LIFE AND FUNCTIONAL STATUS MEASURES IN ADVANCED PARKINSON'S PATIENTS TREATED WITH PRAMIPEXOLE, BROMOCRIPTINE, OR PLACEBO [O] . Greer M, Guttman M, Meier D, 1999

机译：PN4：接受帕吡米索，溴西比汀或普拉索治疗的晚期帕金森氏病患者的生活质量和功能状态措施

Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.

摘要

著录项

相似文献

相关主题

期刊订阅